Houston Wire & Cable Company Reports Results for the Quarter Ended March 31, 2017
May 10, 2017 11:31 am UTC| Business
HOUSTON, May 10, 2017 -- Houston Wire Cable Company (NASDAQ:HWCC) (the “Company”) announced operating results for the first quarter ended March 31, 2017. Selected quarterly results were: Sales of $78.7 million up...
Houston Wire & Cable Company Reports Results for the Quarter Ended March 31, 2017
May 10, 2017 11:31 am UTC| Business
HOUSTON, May 10, 2017 -- Houston Wire Cable Company (NASDAQ:HWCC) (the “Company”) announced operating results for the first quarter ended March 31, 2017. Selected quarterly results were: Sales of $78.7 million up...
Houston Wire & Cable Company Reports Results for the Quarter Ended March 31, 2017
May 10, 2017 11:32 am UTC| Business
HOUSTON, May 10, 2017 -- Houston Wire Cable Company (NASDAQ:HWCC) (the “Company”) announced operating results for the first quarter ended March 31, 2017. Selected quarterly results were: Sales of $78.7 million up...
FTI Consulting Introduces Global Private Capital Advisory Services Offering
May 10, 2017 11:31 am UTC| Business
Offering Unites Global Industry and Subject-Matter Expertise Strengthens Coverage with Addition of Industry Veteran Keith Cox WASHINGTON, May 10, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today introduced the firm’s...
FTI Consulting Introduces Global Private Capital Advisory Services Offering
May 10, 2017 11:31 am UTC| Business
Offering Unites Global Industry and Subject-Matter Expertise Strengthens Coverage with Addition of Industry Veteran Keith Cox WASHINGTON, May 10, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today introduced the firm’s...
Amicus Therapeutics to Present at Two Upcoming Investor Conferences
May 10, 2017 11:31 am UTC| Business
CRANBURY, N.J., May 10, 2017 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer, will present at...
Proteon Therapeutics Receives FDA Breakthrough Therapy Designation for Vonapanitase
May 10, 2017 11:31 am UTC| Business
WALTHAM, Mass., May 10, 2017 -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...